Citation Impact
Citing Papers
Caenorhabditis elegans ADAR editing and the ERI-6/7/MOV10 RNAi pathway silence endogenous viral elements and LTR retrotransposons
2020 StandoutNobel
Serotonin Transporter Genetic Variation and the Response of the Human Amygdala
2002 StandoutScience
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
2013 Standout
GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss
2004
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
A Neurotrophic Model for Stress-Related Mood Disorders
2006 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Neuroplasticity of Neocortical Circuits in Schizophrenia
2007
Pharmacokinetics of selective serotonin reuptake inhibitors
2000
Neurotrophin regulation of neural circuit development and function
2012 Standout
Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome
1996 Standout
Decreased DOPAC in the anterior cingulate cortex of individuals with schizophrenia
1995
Intermediate Cognitive Phenotypes Associated with Schizophrenia
2003
Sex differences in Alzheimer disease — the gateway to precision medicine
2018
Magnetoencephalographic gamma power reduction in patients with schizophrenia during resting condition
2009
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia
2003
Somatic APP gene recombination in Alzheimer’s disease and normal neurons
2018 Nature
The free-energy principle: a unified brain theory?
2010 Standout
Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
2008
Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk
2008
Models of schizophrenia in humans and animals based on inhibition of NMDA receptors
2008
Glutamate and Schizophrenia: Phencyclidine, N‐Methyl‐d‐Aspartate Receptors, and Dopamine–Glutamate Interactions
2007
Be smart, exercise your heart: exercise effects on brain and cognition
2007 Standout
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Neurotrophins and their receptors: A convergence point for many signalling pathways
2003 Standout
Linking “big” personality traits to anxiety, depressive, and substance use disorders: A meta-analysis.
2010 Standout
Abnormal fMRI Response of the Dorsolateral Prefrontal Cortex in Cognitively Intact Siblings of Patients With Schizophrenia
2003
Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis
2004
Developmental expression of a novel murine homeobox gene (Chx10): Evidence for roles in determination of the neuroretina and inner nuclear layer
1994
Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers
2000
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
2019
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Relative risk for cognitive impairments in siblings of patients with schizophrenia
2001
Ketamine
2006
Genetics of human prefrontal function
2003
The neurodevelopmental model of schizophrenia: update 2005
2005
The economy of brain network organization
2012 Standout
Searching for Alternative Phenotypes in Psychiatric Genetics
2003
Stress signalling pathways that impair prefrontal cortex structure and function
2009 Standout
Drug Antioxidant Effects
1991
PCP: from pharmacology to modelling schizophrenia
2004
Evaluating models of the personality–psychopathology relationship in children and adolescents
2006
Rethinking schizophrenia
2010 StandoutNature
Current and evolving treatment strategies for the Alzheimer disease continuum
2020
Cortical Cholinergic Transmission and Cortical Information Processing in Schizophrenia
2005
BrainNet Viewer: A Network Visualization Tool for Human Brain Connectomics
2013 Standout
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
2015
Complexity of Prefrontal Cortical Dysfunction in Schizophrenia: More Than Up or Down
2003
Region-Specific Reduction in Entorhinal Gamma Oscillations and Parvalbumin-Immunoreactive Neurons in Animal Models of Psychiatric Illness
2006
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Genetic Variation in CACNA1C Affects Brain Circuitries Related to Mental Illness
2010
Hierarchical Organization of Human Cortical Networks in Health and Schizophrenia
2008
Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: A 30-Year Study
2010
The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function
2003 Standout
Design of amyloidogenic peptide traps
2024 StandoutNobel
The role of GABA during development of the outer retina in the rabbit
1993
Pathophysiology of early onset schizophrenia
2007
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
Why do many psychiatric disorders emerge during adolescence?
2008 Standout
NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons
2007
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
2006
The molecular neurobiology of depression
2008 StandoutNature
Large-scale brain networks and psychopathology: a unifying triple network model
2011 Standout
Neuroscience, Molecular Biology, and the Childhood Roots of Health Disparities
2009 Standout
Glutamatergic Animal Models of Schizophrenia
2003
Complex network measures of brain connectivity: Uses and interpretations
2009 Standout
Network-based statistic: Identifying differences in brain networks
2010 Standout
Complex brain networks: graph theoretical analysis of structural and functional systems
2009 Standout
Current and Future Treatments in Alzheimer Disease: An Update
2020
Lecanemab in Early Alzheimer’s Disease
2022 Standout
Abnormal neural oscillations and synchrony in schizophrenia
2010 Standout
A theory of cortical responses
2005 Standout
Improved erythrocyte survival with combined vitamin E and selenium therapy in children with glucose-6-phosphate dehydrogenase deficiency and mild chronic hemolysis
1986
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Cortical inhibitory neurons and schizophrenia
2005 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins
2011 StandoutNobel
Medical Uses of Vitamin E
1983
Dietary Carcinogens and Anticarcinogens
1983 StandoutScience
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Glutamatergic Mechanisms in Schizophrenia
2002
Rapid metabolic evolution in human prefrontal cortex
2011 StandoutNobel
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
2001 Standout
Glucose-6-phosphate dehydrogenase deficiency
2008 Standout
Deficiency of vitamin E in the alveolar fluid of cigarette smokers. Influence on alveolar macrophage cytotoxicity.
1986
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
The Neuropsychiatric Inventory
1997 Standout
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
2007
TheCaenorhabditis elegansGeneunc-25Encodes Glutamic Acid Decarboxylase and Is Required for Synaptic Transmission But Not Synaptic Development
1999 StandoutNobel
Works of Michael Egan being referenced
Parental Schizophrenia Spectrum Disorders in Childhood-Onset and Adult-Onset Schizophrenia
2003
Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in Schizophrenia
1999
Relative Risk of Attention Deficits in Siblings of Patients With Schizophrenia
2000
Haloperidol and clozapine increase intraneuronal dopamine metabolism, but not γ-butyrolactone-resistant dopamine release
1993
Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia
2013
The site of commencement of retinal maturation in the rabbit
1985
Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
2019
Reduced Chronic Hemolysis during High-Dose Vitamin E Administration in Mediterranean-Type Glucose-6-Phosphate Dehydrogenase Deficiency
1980
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease
2018
Coadministration of Fluvoxamine Increases Serum
1994